Log in

Kindred Biosciences Price Target & Analyst Ratings (NASDAQ:KIN)

$9.30
-0.20 (-2.11 %)
(As of 01/28/2020 01:46 AM ET)
Today's Range
$9.30
Now: $9.30
$9.56
50-Day Range
$7.74
MA: $8.95
$10.41
52-Week Range
$5.96
Now: $9.30
$11.35
Volume80,900 shs
Average Volume201,859 shs
Market Capitalization$363.55 million
P/E RatioN/A
Dividend YieldN/A
Beta0.4

Analyst Ratings

Kindred Biosciences (NASDAQ:KIN) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
8 Wall Street analysts have issued ratings and price targets for Kindred Biosciences in the last 12 months. Their average twelve-month price target is $14.44, suggesting that the stock has a possible upside of 55.24%. The high price target for KIN is $25.00 and the low price target for KIN is $8.50. There are currently 1 hold rating and 7 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.882.882.882.78
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $14.44$14.44$14.81$14.81
Price Target Upside: 55.24% upside74.37% upside111.61% upside111.61% upside

Kindred Biosciences (NASDAQ:KIN) Consensus Price Target History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Kindred Biosciences (NASDAQ:KIN) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/13/2019HC WainwrightReiterated RatingBuy$17.50 ➝ $16.00Medium
7/16/2019B. RileyDowngradeBuy ➝ Neutral$18.00 ➝ $8.50High
6/11/2019BarclaysInitiated CoverageOverweight ➝ Overweight$13.00Medium
5/23/2019GuggenheimInitiated CoverageBuy ➝ Buy$11.00Medium
5/22/2019Stifel NicolausInitiated CoverageBuy ➝ Buy$14.00Medium
4/26/2019Cantor FitzgeraldSet Price TargetBuy$25.00Medium
4/10/2019AegisInitiated CoverageBuy$16.00Low
3/7/2019Lake Street CapitalLower Price TargetBuy$30.00 ➝ $12.00High
8/7/2018LADENBURG THALM/SH SHDowngradeBuy ➝ NeutralHigh
7/9/2018CL KingUpgradeNeutral ➝ BuyHigh
5/23/2018EuroPacific CanadaInitiated CoverageBuy$16.75Low
(Data available from 1/28/2018 forward)
This page was last updated on 1/28/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel